2026-01-27 - Analysis Report
**Company Overview**
Amphenol Corporation is a multinational electronics manufacturing company.

**Return Comparison**
The return rate of APH (477.02%) is significantly higher than the return rate of S&P 500 (127.58%). The current divergence is 333.70, with a relative divergence of 96.00%.

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 13.0% | 16.0% | 4.0%  | 0.9  | 24.8B  |
| 2017-2019  | 27.0% | 16.7% | 2.0%  | 1.1  | 33.1B  |
| 2018-2020  | 23.0% | 35.5% | -1.0% | 1.0  | 40.0B  |
| 2019-2021  | 80.0% | 35.5% | 16.0% | 1.1  | 53.5B  |
| 2020-2022  | 36.0% | 33.5% | 32.0% | 1.1  | 46.6B  |
| 2021-2023  | 51.0% | 25.0% | 33.0% | 1.1  | 60.7B  |
| 2022-2024  | 91.0% | 19.3% | 62.0% | 1.1  | 85.0B  |
| 2023-2025  | 327.0% | 23.7% | 251.0% | 1.3  | 165.4B |

The company's CAGR has shown a significant increase over the years, with the highest growth rate of 327.0% in the 2023-2025 period. Beta values are consistently above 1, indicating that the company's stock price is more volatile than the S&P 500.

**Recent Stock Price Fluctuations**
|  | Close    | Last-Market  | 5-day SMA | 20-day SMA | 60-day SMA |
|---|----------|---------------|------------|-------------|-------------|
| $ | 155.56   | $155.56 (3.03)| $153.20    | $144.87     | $139.52     |

The stock price has been increasing, with a recent 5-day SMA of $153.20, 20-day SMA of $144.87, and 60-day SMA of $139.52. This indicates a short-term upward trend.

**RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence**
- Market Risk Indicator (MRI): 0.70 (Medium Investment)
- RSI: 68.79
- PPO: 0.60
- Hybrid Signal: Buy (Cash 0%)
- Risk Level: Medium (MRI 0.70)
- Recent (20 days) relative divergence change: -4.00 (worsening)
- 7-day Rank change: 4 (+) (rank up)
- 7-day Dynamic Expected Return change: 11.30 (+) (improving)
- Expected Return (%): 13.60%

The RSI and PPO indicators suggest a moderate buying signal, while the MRI indicates a medium investment risk. The recent relative divergence change indicates a worsening trend, and the 7-day rank change and expected return change suggest an improving trend.

**Recent News & Significant Events**
- [2026-01-26] Fund Update: 170,668 AMPHENOL (APH) shares added to WHITTIER TRUST CO portfolio - Quiver Quantitative (news.google.com)
- [2026-01-26] Buy Amphenol Stock Before Q4 Earnings Report? Here's What to Know - Yahoo Finance (news.google.com)
- [2026-01-26] National Wealth Management Group LLC Purchases New Stake in Amphenol Corporation $APH - MarketBeat (news.google.com)
- [2026-01-26] Fair Isaac to Report Q1 Earnings: What's in Store for the Stock? - The Globe and Mail (news.google.com)
- [2026-01-24] Has Amphenol (APH) Run Too Far After A 97% One Year Share Price Surge - simplywall.st (news.google.com)
- [2026-01-12] Why Amphenol Stock Beat the Market Today - The Motley Fool (news.google.com)

Recent news suggests positive trends for the company, with new investments and purchases of APH shares.

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.78 (~Buy)
- Opinions: 18
- Target Price (avg/high/low): 159.10 / 200.00 / 115.00

The analysts' consensus is positive, with a "Buy" key and a mean of 1.78 (~Buy). The target price range is 159.10 to 200.00, with a low of 115.00.

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-24 | 1.02 | 6.19 B$ |
| 2025-07-25 | 0.9  | 5.65 B$ |
| 2025-04-25 | 0.61 | 4.81 B$ |
| 2024-10-25 | 0.5  | 4.04 B$ |
| 2025-10-24 | 0.5  | 4.04 B$ |

The company's EPS has shown a slight decrease over the past year, from 1.02 to 0.5. Revenue has also decreased, from 6.19B$ to 4.04B$.

**Financial Information**

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $6.19B | 38.09% |
| 2025-06-30 | $5.65B | 36.34% |
| 2025-03-31 | $4.81B | 34.17% |
| 2024-12-31 | $4.32B | 34.29% |
| 2024-09-30 | $4.04B | 33.60% |

The company's revenue has decreased slightly over the past year, from 6.19B$ to 4.04B$. Profit margin has fluctuated but remained relatively stable.

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $12.52B | 9.95% |
| 2025-06-30 | $11.52B | 9.47% |
| 2025-03-31 | $10.30B | 7.16% |
| 2024-12-31 | $9.79B | 7.62% |
| 2024-09-30 | $9.45B | 6.39% |

Equity has increased consistently over the past year, from 9.45B$ to 12.52B$. ROE (Return on Equity) has fluctuated but remained relatively stable.

**Comprehensive Analysis (Summary of previous items)**
The company has shown a significant increase in CAGR over the years, with consistent Beta values above 1. The recent stock price fluctuations indicate an upward trend. The RSI and PPO indicators suggest a moderate buying signal, while the MRI indicates a medium investment risk. Recent news suggests positive trends for the company. The analysts' consensus is positive, with a "Buy" key and a mean of 1.78 (~Buy). The company's EPS has shown a slight decrease, while revenue has decreased slightly over the past year.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.